Clinical Trials Browser

Phase 2 × Hematologic Neoplasms × carmustine, poliferprosan 20 drug combination × Clear all

NCT00439556 2019-09-10

Bortezomib and Chemotherapy in Treating Participants With Lymphoid Malignancies Undergoing Stem Cell Transplant

Phase 2 Completed

40 enrolled 11 charts

LymphoidOther hematologic neoplasm

Lymphoma, Hematologic Neoplasms